Rosigon 4mg Tablet

Tablet
Report Error

Composition FOR Rosigon 4mg Tablet

Rosiglitazone(4mg)

food interaction for Rosigon Tablet

alcohol interaction for Rosigon Tablet

pregnancy interaction for Rosigon Tablet

lactation interaction for Rosigon Tablet

food
alcohol
pregnancy
lactation
Rosigon 4mg Tablet may be taken with or without food.
None
CAUTION
Do not drink alcohol while you are taking this medicine. Rosigon 4mg Tablet may cause excessive drowsiness when taken with alcohol.
UNSAFE
Rosigon 4mg Tablet is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks.
CONSULT YOUR DOCTOR
Rosigon 4mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from the body.
CAUTION

SALT INFORMATION FOR Rosigon 4mg Tablet

Rosiglitazone(4mg)

Rosigon tablet uses

{med_name} is used in the treatment of type 2 diabetes mellitus.

How rosigon tablet works

Rosigon 4mg Tablet is an anti-diabetic medication. It works by increasing the body's sensitivity to insulin, a natural substance that helps control blood sugar levels.

Common side effects of rosigon tablet

Blurred vision, Numbness, Bone fracture, Respiratory tract infection

SUBSTITUTES FOR Rosigon Tablet

14 Substitutes
14 Substitutes
Sorted By
RelevancePrice

Expert advice FOR Rosigon Tablet

  • Rosiglitazone has been withdrawn from the market due to an increased risk of heart attack and heart-related deaths.
  • Rosiglitazone helps to control blood sugar level and avoid long-term complications.
  • Full effects may be visible after several weeks of starting Rosiglitazone. Keep taking it as prescribed by your doctor. 
  • Weight gain, headache, and swelling due to fluid build-up may occur.
  • Notify your doctor if you experience shortness of breath, heart problems, or any abnormal swelling.
  • May not be suitable for patients with a history of heart failure or bladder cancer.
  • You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines along with Rosiglitazone.
  • Take it only as per dose and duration suggested by your doctor. 
  • Monitor your blood sugar level regularly while taking this medicine. 
  • Your doctor may monitor your liver function. Inform your doctor if you notice symptoms like abdominal pain, yellowing of eyes and loss of appetite. 

Frequently asked questions FOR Rosigon 4mg Tablet

Rosiglitazone

Q. Can Rosigon 4mg Tablet be used along with glimepiride in diabetes?
Rosigon 4mg Tablet when added to Glimepiride in patients with diabetes mellitus, has been found to significantly reduce plasma lipid levels and significant improvement in blood glucose control related to a reduction in the insulin resistance.
Q. How to use Rosigon 4mg Tablet?
Rosigon 4mg Tablet is an anti-diabetes drug used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. Pioglitazone acts as an insulin sensitizer and decreases the extent of insulin resistance in the body too.
Q. How does Rosigon 4mg Tablet cause oedema?
Rosigon 4mg Tablet increases the permeability of fluid in tiny blood vessels called capillaries. This results in easier movement of fluids across the membrane and their consequent accumulation, resulting in oedema (puffiness). Also, Pioglitazone causes increased sodium and water reabsorption from the kidney that contributes to the oedema.
Show More
Q. How does Rosigon 4mg Tablet cause heart failure?
Rosigon 4mg Tablet can cause fluid retention and edema. Consequently, there is a lot of fluid in the body (fluid overload). As a result, it may precipitate heart failure (which worsens with fluid overload in those at risk).
Q. Can Rosigon 4mg Tablet be used in depression?
Rosigon 4mg Tablet, either alone or as add-on therapy to conventional treatments, could clinically benefit patients of major depression according to a study

Content on this page was last updated on 31 March, 2026, by Dr. Sachin Gupta (MD Pharmacology, MBBS)